Literature DB >> 21191839

Inhibition of NF-kappa B can enhance Fas-mediated apoptosis in leukemia cell line HL-60.

Li Wang1, Shi Zhao, Hong-Xiang Wang, Ping Zou.   

Abstract

This study explored the effects of nuclear factor-kappa B (NF-κB) inhibitor Bay 11-7082 on Fas/FasL system and Fas-mediated apoptosis in cell line HL-60 cells. The mRNA and protein levels of Fas, FasL, and X-linked inhibitor of apoptosis protein (XIAP) were detected by reverse transcription-polymerase chain reaction (RT-PCR) and flow cytometry (FCM); the level of sFasL was evaluated by enzyme-linked immunosorbent assay (ELISA); and apoptosis was determined by FCM. After treatment with Bay 11-7082, the mRNA and protein levels of FasL and XIAP in HL-60 cells were significantly lower than in the controls (P<0.05), but the mRNA and protein levels of Fas and sFasL did not change significantly (P>0.05). Apoptotic rate of HL-60 cells treated with Bay 11-7082 was significantly higher than in the controls (P<0.05). Therefore, we conclude that Bay 11-7082 can enhance Fas-mediated apoptosis in HL-60 cells by downregulating FasL and XIAP levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21191839     DOI: 10.1007/s11684-010-0026-5

Source DB:  PubMed          Journal:  Front Med China        ISSN: 1673-7342


  23 in total

1.  AKT controls human first trimester trophoblast cell sensitivity to FAS-mediated apoptosis by regulating XIAP expression.

Authors:  Shawn L Straszewski-Chavez; Vikki M Abrahams; Paula B Aldo; Roberto Romero; Gil Mor
Journal:  Biol Reprod       Date:  2009-09-02       Impact factor: 4.285

2.  Type I and type II pathways of Fas-mediated apoptosis are differentially controlled by XIAP.

Authors:  Zhenyue Hao; Tak W Mak
Journal:  J Mol Cell Biol       Date:  2009-10-16       Impact factor: 6.216

3.  Changes in susceptibility to Fas-mediated apoptosis during differentiation of HL-60 cells.

Authors:  M Ohashi; M Iwase; M Nagumo
Journal:  J Leukoc Biol       Date:  2000-03       Impact factor: 4.962

4.  Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells.

Authors:  U Kordes; D Krappmann; V Heissmeyer; W D Ludwig; C Scheidereit
Journal:  Leukemia       Date:  2000-03       Impact factor: 11.528

5.  Fas resistance of leukemic eosinophils is due to activation of NF-kappa B by Fas ligation.

Authors:  Yimin Qin; Blanca Camoretti-Mercado; Lyubov Blokh; Catherine G Long; Franklin D Ko; Kimm J Hamann
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

6.  Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemia.

Authors:  Carlos E Bueso-Ramos; Frederico C Rocha; Shishir Shishodia; L Jeffrey Medeiros; Hagop M Kantarjian; Saroj Vadhan-Raj; Zeev Estrov; Terry L Smith; Martin H Nguyen; Bharat B Aggarwal
Journal:  Hum Pathol       Date:  2004-02       Impact factor: 3.466

7.  Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for CD95-induced apoptosis.

Authors:  Sandra Loeder; Annekathrin Drensek; Irmela Jeremias; Klaus-Michael Debatin; Simone Fulda
Journal:  Int J Cancer       Date:  2010-05-01       Impact factor: 7.396

8.  Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5.

Authors:  Bing Z Carter; Duncan H Mak; Wendy D Schober; Martin F Dietrich; Clemencia Pinilla; Lyubomir T Vassilev; John C Reed; Michael Andreeff
Journal:  Blood       Date:  2008-01-10       Impact factor: 22.113

Review 9.  Signaling and transcriptional control of Fas ligand gene expression.

Authors:  M M Kavurma; L M Khachigian
Journal:  Cell Death Differ       Date:  2003-01       Impact factor: 15.828

10.  Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells.

Authors:  C Friesen; I Herr; P H Krammer; K M Debatin
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

View more
  2 in total

1.  An in vitro study on the effects of the combination of salinomycin with cisplatin on human gastric cancer cells.

Authors:  Zuwen Zhang; Jumei Zhao; Qiuxia Pang; Aihong Wang; Meini Chen; Xiaoli Wei
Journal:  Mol Med Rep       Date:  2017-06-08       Impact factor: 2.952

2.  The impact of Mir-9 regulation in normal and malignant hematopoiesis.

Authors:  Abbas Khosravi; Shaban Alizadeh; Arsalan Jalili; Reza Shirzad; Najmaldin Saki
Journal:  Oncol Rev       Date:  2018-03-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.